艾滋病不治会早死，早治才康复 艾滋病不治会早死，早治才康复 艾滋病不治会早死，早治才康复 艾滋病不治会早死，早治才康复

图示∶2011年5月正式出版的《中国特色医疗金鉴》登载的刘君主任及其机构事迹

慢性艾滋病早期中医药治疗保障生命论证 红津液饮料面世 或将能预防艾滋病 更多来源∶新浪商业登载 http://vic.sina.com.cn/news/27/2010/1231/26801.html TOM新闻登载 http://post-social.news.tom.com/s/63000AD83310.html 中国青年网 健康频道 http://news.youth.cn/jk/201012/t20101231_1447239.htm  环球时报-环球网 http://news.163.com/10/1231/15/6P8B7PTU00014JB6.html  环球网 http://china.huanqiu.com/hot/2010-12/1390550.html

 

 

Scientists said the successful development of AIDS vaccine human trials will be conducted
September 29, 2011 13:28:08
Source: BEIJING
  
   
 
 



Of HIV under the microscope.

28 According to foreign media reports, the Spanish scientists say they have developed a vaccine to prevent AIDS, the future of AIDS treatment and treatment of common herpes may be as simple.

Trial, researchers found that 24 of the test results in 92% of the experimenters injected with MVA-B vaccine have produced antibodies against HIV virus. The project director, Professor Esther said: "If in the future re-emergence of HIV in the body, the lymphatic system can still recognize it."

"Our body is full of the lymphatic system, every different pathogens can resist." Esther said Ben, "the vaccine is to identify the HIV virus to the lymphatic system and resist it." There are two main types of lymphocytes, B cells and T cells, B cells which produce antibodies against the virus, T cells detect and destroy infected cells. Esther said the professor, and now research is still in the early stages, but the study "very promising."

Scientists predict the next step will have been infected with HIV, people who test to see whether the vaccine treatment.

But scientists are very optimistic about this, saying: "MVA-B and other vaccines has been confirmed in the research stage of the vaccine as effective as or even better."

显微镜下的HIV病毒。

　　据外媒28日报道，西班牙科学家声称，他们研制出了预防艾滋病的疫苗，未来艾滋病的治疗或许将和治疗普通疱疹一样简单。

　　试验中，研究者们发现24名测试者中92%的实验者在注射了MVA-B疫苗后都对HIV病毒产生抗体。项目主管埃斯特本教授表示：“如果将来HIV病毒再度出现在人体内，淋巴系统仍旧可以识别它。”

　　“我们的身体内充满了淋巴系统，每一处都能抵御不同的病原体。”埃斯特本说，“疫苗就是让淋巴系统识别HIV病毒并抵御它。”淋巴球有两个主要类型，B细胞和T细胞，其中B细胞产生抗体抵御病毒，T细胞侦察并摧毁受感染的细胞。埃斯特本教授表示，现在研究还处在早期阶段，不过该研究“非常有前途”。

　　科学家预计下一步会在已感染HIV病毒的人身上进行试验，看该疫苗是否有治疗作用。

　　不过科学家们对此感到十分乐观，称：“MVA-B疫苗已证实和其他处在研究阶段的疫苗一样有效，甚至更好。”